Essential thrombocythemia and non-Hodgkin lymphoma: A case report

F. Radaelli, M. Colombi, L. Cro, R. Calori, L. Baldini

Research output: Contribution to journalArticle

Abstract

A 67-year-old man with essential thrombocythemia treated with alkylating agents developed a small lymphocytic lymphoma after 102 months of therapy. Given the rareness of such an association, this case is reported because the cytoreductive treatment may have contributed to the onset of the lymphoma.

Original languageEnglish
Pages (from-to)177-179
Number of pages3
JournalCurrent Therapeutic Research
Volume53
Issue number2
DOIs
Publication statusPublished - 1993

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this